Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Drug repositioning for human MKN45 gastric cancer mouse model using deep learning AI and experimental validation | Synapse
March 3, 2026
Drug repositioning for human MKN45 gastric cancer mouse model using deep learning AI and experimental validation
GG
Ghazaleh Ghavami
Pasteur Institute of Iran
RK
Ramin Ebrahimi Kiasari
Pasteur Institute of Iran
SG
Setareh Ghavami
See all
Key Points
Drug repositioning may identify effective treatments for gastric cancer, enhancing therapeutic options.
Key evidence shows successful application of deep learning AI in validating drug efficacy in a mouse model.
The approach involves a combination of experimental validation with advanced AI techniques for precise outcomes.
Highlighting the need for further validation to confirm findings in broader contexts beyond mouse models.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Ghavami et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7668cbadf0bb9e87dd676
https://doi.org/https://doi.org/10.1016/j.ejphar.2026.178615
Mark Helpful
Like
Save
Bookmark
Relay
Share